Recombinant IL6 (Siltuximab Biosimilar) antibody
Research Grade
Reactivity: Human
ELISA
Host: Mammalian Cells
Monoclonal
unconjugated
Recombinant Antibody
-
- Target See all IL6 (Siltuximab Biosimilar) products
- IL6 (Siltuximab Biosimilar)
- Antibody Type
- Recombinant Antibody
- Reactivity
- Human
-
Host
-
Mammalian Cells
- Expression System
- Mammalian cells
-
Clonality
- Monoclonal
-
Conjugate
- This IL6 (Siltuximab Biosimilar) antibody is un-conjugated
-
Application
- ELISA
- Purpose
- Siltuximab Biosimilar - Anti-IL6 mAb
- Characteristics
- Antibody Type: IgG1Kappa
- Purification
- Recombinant antibody expressed in mammalien cells and purified.
- Grade
- Research Grade
- Isotype
- IgG1 kappa
-
anti-IL6 (Siltuximab Biosimilar) antibody
Research Grade Reactivity: Human ELISA, FACS Host: Mouse Chimeric unconjugated Recombinant Antibody
-
- Restrictions
- For Research Use only
-
- Buffer
- PBS pH 7.5
- Storage
- 4 °C,-20 °C
- Storage Comment
- 4°C for short term, -20°C for long term
-
- Target
- IL6 (Siltuximab Biosimilar)
- Abstract
- IL6 (Siltuximab Biosimilar) Products
- Target Type
- Biosimilar
- Background
-
Siltuximab
The Siltuximab antibody is a chimeric mouse/human therapeutic antibody obtained from mouse hybridoma. It is one of several IgG1 antibodies known to bind the human interleukin 6 (IL-6) molecule, a soluble glycoprotein with a key role in pro-inflammatory responses. IL-6 is one of the main proinflammatory cytokines overexpressed in multiple pathologies (e.g. viral infections, rheumatoid arthritis, MCD, etc.).
-
You are here:
